PRESS RELEASE published on 08/31/2023 at 20:35, 2 years 9 months ago XS Financial Completes Unsecured Convertible Note Repurchase And Cancellation
PRESS RELEASE published on 08/30/2023 at 21:05, 2 years 9 months ago XS Financial Announces Unsecured Convertible Note Repurchase and Cancellation
PRESS RELEASE published on 08/28/2023 at 22:00, 2 years 10 months ago XS Financial Reports Second Quarter 2023 Results
PRESS RELEASE published on 08/17/2023 at 22:00, 2 years 10 months ago XS Financial Announces Date For Q2 2023 Financial Results And Earnings Call
PRESS RELEASE published on 08/07/2023 at 14:00, 2 years 10 months ago XS Financial Provides $7.6 Million CAPEX Financing to PharmaCann Inc.
PRESS RELEASE published on 06/12/2023 at 14:05, 3 years ago XS Financial Announces Amendment to Unsecured Convertible Notes, Maturity Date Extension
PRESS RELEASE published on 06/01/2023 at 22:30, 3 years ago XS Financial Announces the Appointment of Justin Vuong as Its New Chief Financial Officer
PRESS RELEASE published on 05/30/2023 at 22:30, 3 years ago XS Financial Reports First Quarter 2023 Results
PRESS RELEASE published on 05/17/2023 at 14:00, 3 years 1 month ago XS Financial Announces Date for Q1 2023 Financial Results and Earnings Call
PRESS RELEASE published on 05/16/2023 at 14:00, 3 years 1 month ago XS Financial Expands Into Non-Cannabis Industries and Forms Capital Markets Desk
Published on 06/29/2026 at 15:00, 56 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 56 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 1 hour 26 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 1 hour 26 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 1 hour 26 minutes ago US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher
Published on 06/29/2026 at 15:34, 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/29/2026 at 15:30, 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 06/29/2026 at 10:56, 4 hours 59 minutes ago GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
Published on 06/29/2026 at 10:56, 4 hours 59 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
